Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

American Journal of Psychiatry

Volumn 151, Issue 10, 1994, Pages 1430-1436

  Chakos, Miranda H ^a   Lieberman, Jeffrey A ^b   Bilder, Robert M ^b   Borenstein, Michael ^b   Lerner, Gail ^b   Bogerts, Bernhard ^b   Wu, Houwei ^b   Kinon, Bruce ^b   Ashtari, Manzar ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DOPAMINE; NEUROLEPTIC AGENT;

ADULT; AGE; ARTICLE; BRAIN CORTEX; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; LATERAL BRAIN VENTRICLE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0028141509     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.151.10.1430     Document Type: Article

References (44)

1. Bogerts B: The neuropathology of schizophrenia: pathophysiological and neurodevelopmental implications, in Fetal Neural Development and Adult Schizophrenia. Edited by Mednick SA, Cannon TD, Barr CE, Lyon M. New York, Cambridge University Press, 1991
2. Hyde TM, Casanova MF, Kleinman JE, Weinberger DR: Neuroanatomical and neurochemical pathology in schizophrenia, in American Psychiatric Press Review of Psychiatry, vol 10. Edited by Tasman A, Goldfinger SM. Washington, DC, American Psychiatric Press, 1991
3. Andreasen NC, Nasrallah HA, Dunn V, Olsen SC, Grove WM, Ehrhardt JC, Coffman JA, Crossett JH: Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 1986; 43:136-144
4. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Simhadri MG, Henn FA, Anand AK: Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry 1991; 29: 159-175
5. Heckers S, Heinsen H, Heinsen Y, Beckmann H: Cortex, white matter, and basal ganglia in a volumetric postmortem study. Biol Psychiatry 1991; 29:556-566
6. Jernigan TL, Zisook S, Heaton RK, Moranville JT, Hesselink JR, Braff DL: Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry 1991; 48:881-890
7. Swayze VW II, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC: Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992; 31:221-240
8. Nasrallah HA, Chu O, Olsen SC, Martin R: Increased caudate volume in schizophrenia: a controlled MRI study (abstract). Schizophr Res 1993; 9:204
9. Feinberg I: Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1983; 17: 319-334
10. Fields RD, Nelson PG: Activity-dependent development of the vertebrate nervous system, in International Review of Neurobiology, vol 34. Edited by Bradley B. San Diego, Academic Press, 1992
11. Bogerts B, Ashtari M, Degreef G, Alvir JMJ, Bilder RM, Lieberman JA: Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res: Neuroimaging 1990; 35:1-13
12. Lieberman JA, Jody D, Alvir JMJ, Ashtari M, Levy DL, Bogerts B, Degreef G, Mayerhoff DI, Cooper T: Brain morphology, dopamine and eye tracking abnormalities in first-episode schizophrenia: prevalence and clinical correlates. Arch Gen Psychiatry 1993; 50:357-368
13. Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir J, Lieberman JA: Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry 1992; 49:531-537
14. Lieberman JA, Alvir JMJ, Woerner M, Degreef G, Bilder R, Ashtari M, Bogerts B, Mayerhoff DI, Geisler SH, Loebel A, Levy DL, Hinrichsen GA, Szymanski S, Chakos MH, Koreen A, Borenstein MT, Kane JM: Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital: design, methodology and summary of findings. Schizophr Bull 1992; 18:351-371
15. Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein M: Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993; 50:369-376
16. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
17. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35:773-782
18. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1987
19. Ashtari M, Zito JL, Bennett IG, Lieberman JA, Borenstein MT, Herman PG: Computerized volume mensuration of brain structure. J Invest Radiol 1990; 25:798-805
20. Bilder RM, Wu H, Bogerts B, Degreef G, Ashtari M, Alvir JMJ, Snyder PJ, Lieberman JA: Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 1994; 151:1437-1447
21. Andreasen NC, Olsen S: Negative v positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982; 39:789-794
22. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19
23. Simpson GM, Lee JH, Zoubok B, Gardos G: A rating scale for tardive dyskinesia. Psychopharmacology (Berl) 1979; 64:171-179
24. Krishnan KR, Husain MM, McDonald WM, Doraiswamy PM, Figiel GS, Boyko OB, Ellinwood EH, Nemeroff CB: In vivo stereological assessment of caudate volume in man: effect of normal aging. Life Sci 1990; 47:1325-1329
25. Jeste DV, Lohr JB, Manley M: Study of neuropathologic changes in the striatum following 4, 8, and 12 months of treatment with fluphenazine in rats. Psychopharmacology (Berl) 1992; 106: 154-160
26. Stevens JR: Abnormal reinnervation as a basis for schizophrenia: a hypothesis. Arch Gen Psychiatry 1992; 49:238-243
27. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, Kessler R: Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol Psychiatry 1987; 22:479-494
28. Muller P, Seeman P: Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. Life Sci 1977; 21:1751-1758
29. Bogerts B: Hirnatrophische Prozesse bei Schizophrenen - ein Quatitativer Vergleich mit parkinson- und huntington-erkrankung, in Biologische Psychiatrie. Edited by Keup W. Berlin, Springer-Verlag, 1986
30. Benes FM, Paskevich PA, Davidson J, Domesick VB: The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 1985; 329:265-273
31. Benes FM, Paskevich PA, Domesick VB: Haloperidol-induced plasticity of axon terminals in rat substantia nigra. Science 1983; 221:969-971
32. Klintzova AJ, Haselhorst NA, Ranova NA, Schenk H, Istomin VV: The effects of haloperidol on synaptic plasticity in rat's medial prefrontal cortex. J Hirnforsch 1989; 1:51-57
33. Meshul CK, Casey DE: Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res 1989; 489:338-346
34. Peichl L, Bolz J: Kainic acid induces sprouting of retinal neurons. Science 1983; 223:503-504
35. Casanova MF, Comparini SO, Kim RW, Kleinman JE: Staining intensity of brain iron in patients with schizophrenia: a postmortem study. J Neuropsychiatry Clin Neurosci 1992; 4:36-41
36. Campbell WG, Raskind MA, Gordon T, Shaw CM: Iron pigment in the brain of a man with tardive dyskinesia. Am J Psychiatry 1985; 142:364-365
37. Hunter R, Blackwood W, Smith MC, Cumings JN: Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication. J Neurol Sci 1968; 7:263-273
38. Weiner WJ, Nausieda PA, Klawans HL: Effect of chlorpromazine on central nervous system concentrations of manganese, iron, and copper. Life Sci 1977; 20:1181-1185
39. Pujol J, Jungue C, Vendrell P, Grau J, Mart-Vilalta JL, Olive C, Gili J: Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol 1992; 49:711-717
40. Unger EC, Cohen MS, Brown TR: Gradient-echo imaging of hemorrhage at 1.5 Tesla. Magn Reson Imaging 1989; 7:163-172
41. Atlas SW, Mare AS, Grossman RI, Gomori JM: Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Radiology 1988; 168:803-807
42. Brasch RC, Wesbey GE, Gooding CA, Koerper NA: Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major. Radiology 1984; 150:767-771
43. 2-weighted MR images. Radiology 1989; 173:311-312
44. Janson AM, Fuxe K, Goldstein M, Deutch AY: Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion. Exp Brain Res 1991; 87:232-238